Vapor
Hanwha Q CELLS USA has replied to a lawsuit in the US District Court for the District of Delaware filed by REC Group (REC), a subsidiary of China National Chemical Corp.
Hanwha Q CELLS has claimed that
REC’s alleged complaints and the patent are without technical and legal
merit. They stated that the technology mentioned in REC’s statement only
pertains to the arrangement of solar components within a solar module,
which is utilised by most module manufacturers in the industry. This
patent was registered in August 2020. They have also intended to file a
Post Grant Review (PGR) to challenge the validity of the concerned
patent.
As per Hanwha Q CELLS, they have established operations
in the U.S., opening a factory and investing in their production bases
and also contributing to local job creation. They claimed that as they
have an unchallenged leading position in the US photovoltaic market in
both residential and commercial markets, they can easily succeed in
proving the invalidity of REC’s patent in the US.
Earlier this week, REC Group had filed a Patent Infringement Lawsuit against Hanwha Q Cells in an American District Court.
At
the time, Dr. Shankar G. Sridhara, Chief Technology Officer of REC
Group. had explained “REC Group’s R&D resources, time, and
investments have significantly contributed to a new set of industry
standards. REC Group filed this action to protect its intellectual
property, investments, and reputation, as well as to encourage more
innovation in the industry.
“The more solar companies invest in
developing groundbreaking innovation, the more improvement we will see
inefficiencies and costs per kWh and achieving full access to renewable
energy generation and consumption for communities. As a global,
pioneering solar energy company, we champion intellectual property
rights and fair competition. This also means that we will rigorously
defend our rights when they are being violated.”
Source:www.saurenergy.com
Editor:Vapor